Tirzepatide — lab test, February 2026
Vanguard Laboratory publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
Not on file for this certificate: sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 60 mg · Lab measured 67.2 mg
112% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 16.8 mg using the measured mass, against 15 mg on the label — 12% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of Tirzepatide, performed by Vanguard Laboratory on February 23, 2026. Reported purity: 99.8%. Net content: 67.2 mg against 60 mg labeled (112% of label). Tested content exceeds the labeled amount by 12%. Endotoxins: 0.70 EU/mg. Batch 251220TZ603. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion